Cigna (NYSE:CI) beats Q3 2026 sales expectations
Cigna (NYSE:CI) reported Q3 2026 revenue of $73.79B, up 6.1% YoY and 1.5% above estimates. Adjusted EPS was $7.98, 6.3% higher than expected. Operating margin was 2.9%, in line with the prior year. The company's customer base grew to 16.7M. Management highlighted strategic priorities for growth. Analysts expect 3.7% revenue growth over the next 12 months.
How this was made

The 30-second read
Why it matters
The earnings beat drove a 1.9% share price rise and may influence analyst revisions.
Market read
Fresh earnings beat provides a short-term trading catalyst for CI.
What to watch
Slower margin expansion and decelerating revenue growth outlook could temper enthusiasm.
Background
Cigna's Q3 2026 earnings were released, showing revenue and EPS beats versus consensus.
Ticker impact
Cigna reported Q3 2026 revenue of $73.79B and adjusted EPS of $7.98, both beating analyst estimates.
likely modest upward pressure as the market prices in the revenue and EPS beat
The beat is fresh, sizable relative to expectations and the stock moved up 1.9% immediately after release.
Market effects
Health insurance sector may see modest rally on stronger-than-expected earnings.
U.S. market participants may adjust exposure to insurers.
Limited to U.S. insurers; no broader macro impact.
Counterpoint
The beat may be priced in quickly, limiting upside.
Key entities
- companyCigna
Health insurance provider reporting Q3 2026 earnings.



